|
|
Reducing Hospitalizations: CABP Management Updates for Primary Care
|
|
Facebook
LinkedIn
E-Mail
|
(368)
Other: Antibiotic, Assessment, Diagnosis, Emergency, Evaluation (Follow-up), Evidence-Based Guidelines, Imaging Selection/Interpretation, Infectious Disease, Laboratory Interpretation, Lung Disease, Pneumonia/Respiratory Infections, Primary Care, Pulmonary, Treatment, Treatment Plan, Vaccinations
(show less)
|
Released: 09/01/2021
Expires: 09/30/2022 (subject to change)
- CE for this activity will not be available after this date.
Overview
Community acquired bacterial pneumonia (CABP) is a leading cause of hospitalization and death in the US. Antibiotic resistance is one of the biggest health challenges in the US and NPs are ideally situated to respond to the call for antibiotic stewardship. In this audio-visual presentation, a primary care NP and an emergency NP guide the learner through the updated ATS/IDSA guidelines for community acquired pneumonia. This activity also includes a thorough review of current pharmacologic treatments including newer agents and discussion of antimicrobial stewardship. A tracer case study follows a patient from the primary care setting to the emergency room and back to primary care for follow up.
Objectives
- Outline current national guidelines for community acquired bacterial pneumonia (CABP) diagnosis and management in the outpatient setting.
- Discuss antimicrobial stewardship in the context of CABP.
- Compare and contrast antimicrobial treatments for CABP including newer agents.
Speakers
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAPMichael D. Gooch, DNP, APRN, CCP, ACNP-BC, FNP-BC, ENP-C
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.
Wendy Wright has the following disclosures:- Merck, Pfizer, Sanofi-speakers bureau and consultant-vaccines
- Biohaven, AbbVie-speakers bureau
- Gilead and GSK-consultant
Michael Gooch has nothing to disclose.
All Planners involved in this activity have no relevant financial relationships to disclose. This activity is supported by an independent medical education grant from Nabriva Therapeutics.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Accreditation Information
This activity has been accredited by the American Association of Nurse Practitioners (AANP) and the American Academy of PAs (AAPA).AANP Accreditation Information:
This American Association of Nurse Practitioners has approved this activity for 2.50 contact hour(s) of continuing education, 1.00 of which can be used towards pharmacology. Activity ID# 21054990. This activity was planned in accordance with AANP Accreditation Standards and Policies. | 
| AAPA Accreditation Information:
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 2.50 AAPA Category 1 CME credits. Approval is valid from 9/1/2021 to 03/31/2023. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-202899.
| |
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Complete the Pretest associated to the activity.
- Complete the educational content:
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Complete the post-test and pass with a score of at least 70% (4 attempts allowed).
- Submit the evaluation to receive full AANP CE/Rx credit.
Additional Information
For questions or more information concerning this online CE opportunity contact the AANP CE Center Support Team at CECenter@aanp.org.
2.5 Contact Hour(s) of CE,
1 of which may be applied towards Pharmacology
|
|
|
|
Adding Registration, Please wait...
